Nanjing Vazyme Biotech Co Ltd (688105) — Cash Flow Reinvestment Rate
Nanjing Vazyme Biotech Co Ltd (688105) has a Cash Flow Reinvestment Rate of 0.21x as of September 2025, reinvesting CN¥15.83 Million (capex CN¥15.83 Million ) from operating cash flow of CN¥75.30 Million. Check 688105 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Nanjing Vazyme Biotech Co Ltd Cash Flow Reinvestment Rate (2019–2025)
Historical reinvestment intensity for Nanjing Vazyme Biotech Co Ltd across 6 annual periods. Explore cash flow to debt ratio of Nanjing Vazyme Biotech Co Ltd to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Nanjing Vazyme Biotech Co Ltd (2019–2025)
Year-by-year capital reinvestment analysis for Nanjing Vazyme Biotech Co Ltd. For live market cap and broader valuation context, see Nanjing Vazyme Biotech Co Ltd market cap and net worth.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.39x | CN¥323.20 Million | CN¥233.16 Million | CN¥47.39 Million | ▼ -75.7% |
| 2023 | 5.71x | CN¥1.13 Billion | CN¥198.40 Million | CN¥232.90 Million | ▲ +119.3% |
| 2022 | 2.61x | CN¥1.92 Billion | CN¥735.17 Million | CN¥962.86 Million | ▼ -4.9% |
| 2021 | 2.74x | CN¥1.69 Billion | CN¥616.80 Million | CN¥261.96 Million | ▲ +102.8% |
| 2020 | 1.35x | CN¥1.09 Billion | CN¥803.55 Million | CN¥152.54 Million | ▼ -36.0% |
| 2019 | 2.11x | CN¥32.08 Million | CN¥15.20 Million | CN¥19.88 Million | — |